ABSTRACT. The predominance of taurine (Tau) conjugated over glycine conjugated bile acids in infants fed human milk a s opposed to those on formulas without added Tau could account for a more complete absorption of fat. Fifteen low birth weight infants were randomized to either Enfamil Premature or to Enfamil Premature added with 40 pmol/dl of Tau and compared to a third group made up of nine low birth weight infants fed their own mother's preterm milk. Formulas and human milk were fed according to tolerance and constituted the sole nutrition for 3 months. A metabolic study was carried out at 3 wk of age and control of growth was done periodically. Urinary Tau excretion (pmol/dl) was very low (p < 0.001) in the group fed Enfamil Premature (0.3 f 0.1) when compared to the values obtained in infants supplemented with Tau (51.6 + 12.5 ) and in those on human milk (36.3 f 7.9). Infants supplemented with Tau (92.5 f 1.2) had a coefficient of fat absorption which was higher ( p < 0.05) than the unsupplemented group (87.5 f 7.9 ) and comparable to the human milk-fed group (91.6 +: 1.4 ). The effect was more pronounced on the saturated fatty acids and varied inversely with their individual water solubility. There was no effect of Tau on nitrogen retention and growth was identical in the three groups. These data show that the addition of 'Tau to formula had no effect on growth but improved the absorption of fat especially saturated fatty acids which require higher concentrations of bile acids to form mixed micelles. (Pediatr Res 22: 67-71, 1987) In recent years, taurine has been the subject of increasing interest in view of its role on the retina, the central nervous system, liver function, and growth (1). Taurine fits the definition of a "conditionally essential" nutrient (2) because synthesizing capacity is limited and therefore needs cannot be met when dietary intake is inadequate or when losses are increased. The dietary dependency for taurine has been demonstrated in animal species (3, 4) and in man (5) . Two clinical studies have addressed the issue of increased needs in certain disease conditions (6, 7). Other reports (8) (9) (10) have examined the role of supplemental taurine in preterm infants since the young of most species are thought to synthesize taurine less well than their adult conterparts (1 1).
The only well-characterized metabolic reaction of taurine is its conjugation with bile acids in the liver (1). Conjugation of bile acids is catalyzed by a single liver enzyme, n-acetyl transfer-ase, which has greater affinity for taurine than for glycine. As a result, the percentage of bile acids conjugated with taurine is closely correlated with the hepatic pool of taurine which in turn is dependent on the dietary intake (12) . In contrast to human milk or taurine supplemented formula fed infants those who are offered formulas without added taurine have a predominance of glycine conjugated bile acids by 4 wk of age and low urinary taurine concentrations (8) (9) (10) 13) .
There are theoretical advantages of tauroconjugates over glycoconjugates with regard to fat absorption. Tauroconjugates have a lower pKa and are therefore more likely to remain in solution when bicarbonate secretion is impaired through immaturity or defective exocrine pancreatic function ( 14) . Furthermore tauroconjugates are mostly absorbed in the ileum (15) and could be more available to form mixed micelles with fat which escapes proximal absorption in preterm infants. This hypothesis appeared reasonable given the fact that preterm infants are fed large amounts of lipids and have low intraduodenal bile acid concentrations ( 16) . However the two studies examining the effect of taurine-supplemented formulas have failed to show improved fat absorption (8, 10) . Having recently reported that taurine supplements decrease fatty acid losses in cystic fibrosis patients with a high glycine/taurine ratio of conjugated bile acids (7) it was elected to conduct a further study.
PATIENTS AND METHODS
A total of 24 low birth weight infants were studied. Admission to the protocol required that they were free of major congenital abnormalities, hemolytic disease, hyaline membrane disease, and notable respiratory distress. As shown in Table I , they were all appropriate for gestational age. The study protocol was approved by the Ethics Committee of H6pital Ste-Justine, Montreal, Canada and informed consent was obtained from the parents.
Within the first 48 h of life, babies were randomized to Enfamil Premature Formula with or without added taurine at the concentration of 40 pmol/dl found in preterm milk (17) . The macronutrient composition and caloric density of the formula is shown in Table 2 . A third group was made up of infants who were fed their own mothers' milk which was not heat treated. Routine care was provided. The large majority received intravenous therapy during the first few days and were gradually introduced to gavage feedings of formula or expressed human milk. The amounts given in this fashion depended on the individual baby's tolerance assessed clinically and determined by the amount of residual formula present in the stomach. None of the gavage-fed babies had nonnutritive sucking. Once bottle feeding was initiated, intake was regulated by the neonate.
A 3-day metabolic balance study was conducted on each infant during the 4th wk of life (Table I) . Babies were placed on metabolic beds that permitted urine to flow into a glass bottle held on ice. Small plastic collecting bags were fitted around the $ Determined by bomb calorimetry anus to collect the stools which were immediately placed on dry ice kept at the bedside. Stools were collected between two carmine red markers consisting of 200 mg of powder dissolved in 100 ml of formula or human milk and given 72 h apart. A special nurse assistant was in attendance around the clock for babies who were on the metabolic bed. Babies were held while being fed and were handled just as frequently during the balance study through the use of plastic bags that were tied to the waist to prevent loss of urine. Infants were usually discharged when they reached a weight of 2000 g and continued to feed exclusively on the same formula or on human milk until 3 months of age. Growth measurements were monitored during the hospital stay and periodically into the follow-up clinic. A fixed headboard with sliding footboard was used to measure length while the same plastic-coated tape measure was used for recording occipitofrontal circumference. None of the babies initially recruited had to be dropped from the study protocol.
Weighed aliquots of formula, 24-h pools of human milk and 72-h stool homogenates were lyophilized and then submitted to calorimetric analysis (20) . Losses of energy in the urine have been estimated from excreted urea and carbohydrate and correspond to 0.86 kcal/kg/day (2 1). In the present study, an empirical figure of 0.9 kcal/kg/day was used to represent the urinary loss of energy. Metabolizable energy was calculated as the difference between energy intake and losses in the stools and with urine. Total nitrogen in urine, stool, formula, and human milk was measured by a modified Kjeldahl digestion procedure (22) . Urinary taurine was determined by ion exchange chromatography on sulfonated polyestyrene beads linked to divinyl benzene, using an LKB Alpha Plus 4 15 1 analyzer and a Hewlett Packard 3392 A integrator (23) .
The technique used for fat was recently described by this laboratory (24). It does not require extraction prior to direct transesterification which is then followed by injection into an HP 5880 gas chromatograph using a 30-m fused silica column wall coated with SP-2330. As an internal standard is added to fecal homogenate in this one-step reaction, precision of analysis is much higher. A more complete recovery of fatty acids from complex lipids is due to the fact that they are directly and completely freed from biological specimens during the transesterification procedure canied out at 100" C for 1 h and that there is no loss during the evaporation steps which are circumvented. The coefficient of variation for the different fatty acids varied from 0.4 to 2.0% with this methodology.
Analysis of variance was done using a priori orthogonal contrasts (25) involving comparison between the two formula groups and between the human milk group and the two formula groups taken together.
RESULTS
The effect of taurine supplementation on the urinary excretion of taurine was striking (Table 3) . Whether expressed as a concentration or as total excretion over a 72-h period, urinary taurine in the supplemented group was comparable to that of the human milk group and was more than a 100-fold higher than that of neonates fed the formula without taurine.
The energy intake of the three groups differed significantly during the week of the metabolic balance study (Table 4) . However, there was no difference in the percent of calories absorbed or in the metabolizable energy expressed as a percent of intake. Results of the fat balance study are shown in Table 5 . There was no difference in the fat intake between the three groups. The percent fat absorption was higher in the taurine-supplemented infants and comparable to the group fed preterm human milk. Taurine had no effect on the absorption of medium-chain triglycerides but did improve that of unsaturated fatty acids. The data for the total saturated fatty acids show that preterm human milk had a distinct advantage over the two other groups. However, it is noted that taurine supplementation increased the of saturated fatty acids in the formula increased by 4, 10, and 1596, respectively. Results of the nitrogen balance study are shown in Table 6 . Babies on preterm human milk were at a disadvantage compared to the two formula groups; their nitrogen intake and retention were lower. However, when nitrogen retention was expressed as a percent of intake, there was no difference between the human milk group and the two others. Addition of taurine to the formula had no effect on overall nitrogen retention. Growth data (Table  7) obtained over a period of 3 months failed to demonstrate any advantagc of taurine supplementation or any difference in the growth dynamics between the preterm human milk group and the two others.
DISCUSSION
This clinical study involving three groups of healthy preterm infants closely matched for birth weight, gestational age as well as for height, weight, and head circumference indices shows that taurine supplementation of a premature formula had a beneficial effect on fat absorption.
The overall decrease in the amount of fat sequestered in the stools did not lead to a significant sparing of metabolizable energy or to a change in nitrogen retention and growth. However, the percent of fat absorption was comparable to that achieved by the group of babies fed preterm human milk. This observation is of interest in view of all previous studies showing a significant advantage of nonheated mother's milk over formulas with regard to fatty acid absorption (26) (27) (28) (29) (30) . Analysis revealed that 5 1.2% of the lipids in the formula were medium-chain triglycerides as opposed to an average of 9% in the samples of pooled preterm human milk. The fact that the medium-chain triglycerides were almost completely absorbed (>98%) probably accounts for the observation that total fatty acid absorption did not differ between the taurine-supplemented and the human milk-fed groups.
The pattern of fatty acid excretion in response to preterm $ p < 0.01 preterm human milk versrts two formulas. human milk and to the premature formula shows that the effect of taurine was more marked for the saturated fatty acids than for the unsaturates. An inverse relationship was recently reported between increasing chain length of saturated fatty acids and absorption (31) . The present study confirms this finding and shows that taurine was particularly effective in promoting the absorption of palmitic and stearic acids identified as the major fecal fatty acids in neonates (32) . It had less effect on the more polar unsaturated fatty acids largely made up of oleic and linoleic acids and none on the highly water soluble medium chain fatty acids.
The beneficial effect of taurine on fat absorption contrasts with the negative results reported in two studies (8, 10) . In the first study, a lower concentration (30 pmol/dl) of taurine than that present in full-term and preterm human milk (17) was provided. The second study provided the same amount of taurine as in the present study but it can be faulted for the small number (five) of subjects and for the fact that they were studied over an extended period of time. It should also be noted that the fatty acid composition of the formula used in previous studies contained proportionately higher quantities of C 14:0, C 16:0, and C18:O. These fatty acids require a higher concentration of bile acids and presumably of physiologically available tauroconjugates to achieve the results reported herein. Perhaps a further critical aspect concerns the methodology for fat analysis. The one step direct transesterification procedure prior to GC analysis (24) circumvents all extraction procedures and is much more precise then the classical techniques used in the two other studies.
By 1 month of age, preterm infants fed a taurine-free formula have a predominance of glycine conjugates while those on a taurine-supplemented regimen have a glycineltaurine ratio of bile acid conjugates similar to that of infants on human milk (8) .
Although the glycine/taurine pattern of conjugation was not measured in the present study, it can be presumed that a predominance of taurine conjugates resulted from the supplementation especially since the concentration used, 40 pmolldl, is the one found in preterm human milk (17) . The amount of taurine needed to conjugate bile acids is small (*5%) in relationship to the total body pool (33) which is regulated by the kidney (1). Nevertheless the hepatic pool size of taurine closely influences the bile acid conjugation pattern which in turn is dependent on dietary intake (12) . The greater than 100-fold increase in urinary taurine excretion in babies supplemented with taurine contrasts with the hypotaurinuria of the infants fed the premature formula without added taurine and suggests that a shift in the conjugation pattern of bile acids must have resulted from taurine supplementation.
A previous study did not show that taurine supplementation modified bile acid kinetics or their intraluminal concentrations (29) . The improvement noted in fat absorption suggests that the shift in the conjugation pattern in favor of taurine conjugates probably improved the intraluminal phase of fat digestion and absorption. Because of the higher pKa values of glycoconjugates, it is possible that a larger percentage of glycoconjugates than tauroconjugates would precipitate out at an acid pH. As a result, they would not be physiologically available to form micelles with lipolytic products. This may be particularly critical in preterm babies who are known to have defective exocrine pancreatic function (34) . It is true that a recent in vivo study in adults with intestinal resection has failed to show that taurine supplementation decreased duodenal bile acid precipitation or improved the percentage of lipids in micellar solution (35) . However, it should be noted that fat absorption was not studied and that none of these subjects had intraluminal bile acid deficiency (<4 mmol/ liter) which is documented in more than 50% of preterm infants studied at I month of age (29) .
Although glycine conjugates are capable of dispersing more lipids than tauroconjugates they are reabsorbed to a greater extent by passive diffusion in the jejunum (14) . This could compromise micellar solubilization in the lower small bowel, a reserve area for fat absorption. The lower small bowel is recruited for absorption whenever bile acid deficiency exists or when large amounts of fat overcome the digestive-absorptive capacity of the upper jejunum (36) . An indication that taurine possibly improved the shuttle of digested fat between the bulk water phase and the absorptive surface (37) is derived from the data on the fecal sequestration of individual fatty acids. The response to taurine was modest for the coefficient of absorption of unsaturates when compared to the saturates. Because of their poor solubility in . water, the latter require a higher concentration of bile acids to be incorporated into micelles: furthermore saturated fatty acids require a greater length of intestine to be absorbed (38) . The percentage reduction of fatty acid loss for myristic, palmitic, and stearic acid increased as their individual aqueous solubility decreased suggesting that tauroconjugates were available to form micelles with fatty acids which had escaped absorption in the upper jejunum.
In summary, this study has shown that taurine supplementation of premature formulas improves the coefficient of fat absorption, particularly that of those fatty acids which, because of their lack of polarity, require larger concentrations of bile acids and a longer length of intestine to be absorbed. Taurine supplements were recently found to decrease steatorrhea (7) and to improve postprandial chylomicronemia in cystic fibrosis (39) , the present study suggests that this "conditionally essential" nutrient also has a place in the formulas designed for preterm infants.
